
Here are some helpful terms to keep in mind as you navigate your endometrial cancer diagnosis and begin your treatment plan.
Advanced (Stage III or IV) endometrial cancer: When the cancer has spread outside of the uterus to sites such as the lymph nodes, pelvis, vagina, bladder, or liver.
Biomarker: A measurable sign of normal or abnormal processes, conditions, or diseases.
Biomarker test: A laboratory method that looks for biomarkers to help you and your doctor determine an appropriate treatment plan.
Chemotherapy*: A treatment that can destroy fast-growing cells—such as cancer cells—in the body. Since chemotherapy* can destroy fast-growing cells, healthy cells may also be affected.
Deficient mismatch repair (dMMR): Describes a type of endometrial cancer with an inability to repair certain types of DNA damage. It is determined by a biomarker test looking at mismatch repair (MMR) status.
Endometrial cancer (EC): A type of cancer that starts in the inner lining of the uterus, called the "endometrium."
Immunotherapy: A type of cancer treatment that works with your body's immune system to help fight cancer. Immunotherapy may also cause the immune system to attack healthy cells.
Infusion: Also called intravenous (IV) therapy, this is given through a needle to put medicine directly into the bloodstream.
Initial treatment: The first part of treatment, which includes IMFINZI with chemotherapy.*
Maintenance therapy: The second part of treatment given over a longer period of time. During maintenance, IMFINZI is given alone.
PD-L1: A protein that helps disguise cancer cells from the immune system.
Progression-free survival (PFS): The amount of time that patients enrolled in a study lived without their cancer growing or spreading.
Recurrent endometrial cancer: When endometrial cancer that was treated before has returned.
*Carboplatin and paclitaxel.
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
IMFINZI is a prescription medicine that is used in combination with the chemotherapy medicines carboplatin and paclitaxel followed by IMFINZI alone to treat a type of uterine cancer called endometrial cancer that has spread (advanced) or has come back (recurred) and a laboratory test shows that your tumor is mismatch repair deficient (dMMR).
It is not known if IMFINZI is safe and effective in children.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI if you have severe side effects.
Before you receive IMFINZI, tell your healthcare provider about all of your medical conditions, including if you:
Females who are able to become pregnant:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of IMFINZI when used with platinum-containing chemotherapy in adults with endometrial cancer include inflammation of the nerves causing numbness, weakness, tingling or burning pain of the arms and legs, muscle or bone pain, nausea, hair loss, feeling tired, stomach (abdominal) pain, constipation, rash, decreased level of magnesium in the blood, increased liver function tests, diarrhea, vomiting, cough, decreased level of potassium in the blood, shortness of breath, headache, increased level of alkaline phosphate in the blood, and decreased appetite.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Ask your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca products. If you prefer to
report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca products. If you prefer to
report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
IMFINZI is a prescription medicine that is used in combination with the chemotherapy medicines carboplatin and paclitaxel followed by IMFINZI alone to treat a type of uterine cancer called endometrial cancer that has spread (advanced) or has come back (recurred) and a laboratory test shows that your tumor is mismatch repair deficient (dMMR).
It is not known if IMFINZI is safe and effective in children.
Please see Full Prescribing Information including Medication Guide for IMFINZI.
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can affect...
IMFINZI is a medicine that may treat...
IMFINZI is a prescription medicine that is used in combination with the chemotherapy medicines carboplatin and paclitaxel followed by IMFINZI alone to treat a type of uterine cancer called endometrial cancer that has...
IMFINZI is a medicine that may treat certain cancers by work...
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to...